Newswire

Gordon Guyatt Critiques Misuse of Gender-Affirming Care Reviews to Justify Bans

Clinical epidemiologist Gordon Guyatt has publicly condemned the ‘egregious misuse’ of findings from systematic reviews he co-authored on gender-affirming care for minors. Earlier this year, Guyatt worked alongside a Ph.D. student to evaluate the safety and effectiveness of puberty blockers, hormones, and top surgery, aiming for an objective assessment in a highly contentious area of healthcare.

As a professor at McMaster University and a pioneer of evidence-based medicine, Guyatt has dedicated over 45 years to scrutinizing medical interventions through systematic reviews. His methodology for the gender-affirming care studies adhered to the same rigorous standards he has employed throughout his career. The implications of his critiques are significant, as they highlight the potential for scientific data to be misinterpreted or misapplied in policy discussions, particularly concerning vulnerable populations seeking gender-affirming treatments.

Explore deeper: the API & FDF Intelligence database is more than a directory. It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence. You’ll find: – Price ranges for APIs, excipients, and formulations. – DMF, CEP, and GMP compliance status. – Manufacturer portfolios by product and geography. – Direct contacts for every producer and FDF holder, ready for outreach. Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →